- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 213/32 - Atomes de soufre
Détention brevets de la classe C07D 213/32
Brevets de cette classe: 74
Historique des publications depuis 10 ans
|
8
|
8
|
6
|
5
|
2
|
4
|
0
|
3
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bristol-myers Squibb Company | 4725 |
8 |
| Sumitomo Chemical Company, Limited | 9018 |
4 |
| Dow AgroSciences LLC | 1189 |
4 |
| BASF SE | 21313 |
3 |
| Allergan, Inc. | 2170 |
3 |
| Canbas Co., Ltd. | 20 |
3 |
| General Incorporated Association Pharma Valley Project Supporting Organization | 18 |
3 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 186 |
3 |
| T. Hasegawa Co., Ltd. | 92 |
3 |
| Dow Silicones Corporation | 2105 |
3 |
| The Procter & Gamble Company | 21856 |
2 |
| Mitsubishi Chemical Corporation | 4717 |
2 |
| Ecolab USA Inc. | 5789 |
2 |
| Syngenta Participations AG | 1530 |
1 |
| Massachusetts Institute of Technology | 10237 |
1 |
| The Regents of the University of Michigan | 4970 |
1 |
| President and Fellows of Harvard College | 6085 |
1 |
| The Brigham and Women's Hospital, Inc. | 2282 |
1 |
| Congenia S.r.l. | 4 |
1 |
| The Doshisha | 230 |
1 |
| Autres propriétaires | 24 |